- Home
- PHAT vs URG Comparison
PHAT vs URG Comparison
Compare PHAT & URG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- URG
- Stock Information
- Founded
- PHAT 2018
- URG 2004
- Country
- PHAT United States
- URG United States
- Employees
- PHAT N/A
- URG N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- URG Precious Metals
- Sector
- PHAT Health Care
- URG Basic Materials
- Exchange
- PHAT Nasdaq
- URG Nasdaq
- Market Cap
- PHAT 769.0M
- URG 631.2M
- IPO Year
- PHAT 2019
- URG N/A
- Fundamental
- Price
- PHAT $11.70
- URG $1.91
- Analyst Decision
- PHAT Strong Buy
- URG Strong Buy
- Analyst Count
- PHAT 5
- URG 4
- Target Price
- PHAT $16.40
- URG $2.50
- AVG Volume (30 Days)
- PHAT 1.3M
- URG 10.2M
- Earning Date
- PHAT 11-06-2025
- URG 11-05-2025
- Dividend Yield
- PHAT N/A
- URG N/A
- EPS Growth
- PHAT N/A
- URG N/A
- EPS
- PHAT N/A
- URG N/A
- Revenue
- PHAT $114,039,000.00
- URG $39,488,000.00
- Revenue This Year
- PHAT $213.11
- URG N/A
- Revenue Next Year
- PHAT $91.84
- URG $199.04
- P/E Ratio
- PHAT N/A
- URG N/A
- Revenue Growth
- PHAT 1049.82
- URG 149.20
- 52 Week Low
- PHAT $2.21
- URG $0.55
- 52 Week High
- PHAT $19.50
- URG $1.98
- Technical
- Relative Strength Index (RSI)
- PHAT 50.37
- URG 73.92
- Support Level
- PHAT $10.33
- URG $1.69
- Resistance Level
- PHAT $12.97
- URG $1.82
- Average True Range (ATR)
- PHAT 0.89
- URG 0.10
- MACD
- PHAT -0.11
- URG 0.01
- Stochastic Oscillator
- PHAT 45.41
- URG 77.38
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.